| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.88 | 0.003 | 0.88 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | 0.627 0.004 DBMET00259 0.815 0.003 DBMET00260 | ||
| 0.684 | 0.008 | 0.684 | 5 Hydroxytryptamine release stimulant | 0.595 0.015 DBMET00259 0.651 0.01 DBMET00260 | ||
| 0.612 | 0.004 | 0.612 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | 0.462 0.009 DBMET00259 0.547 0.005 DBMET00260 | ||
| 0.615 | 0.017 | 0.745 | Aldehyde oxidase inhibitor | 0.49 0.034 DBMET00259 0.745 0.005 DBMET00260 | DBMET00260 | |
| 0.549 | 0.011 | 0.549 | Cardiotonic | 0.4 0.029 DBMET00259 0.48 0.017 DBMET00260 | ||
| 0.542 | 0.005 | 0.542 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | 0.385 0.012 DBMET00259 0.502 0.005 DBMET00260 | ||
| 0.543 | 0.021 | 0.543 | 5 Hydroxytryptamine release inhibitor | 0.433 0.059 DBMET00259 0.541 0.021 DBMET00260 | ||
| 0.501 | 0.006 | 0.501 | Death-associated protein kinase 3 inhibitor | 0.382 0.02 DBMET00259 0.464 0.009 DBMET00260 | ||
| 0.495 | 0.024 | 0.495 | Immunomodulator | 0.491 0.024 DBMET00259 0.443 0.033 DBMET00260 | ||
| 0.47 | 0.005 | 0.47 | 5 Hydroxytryptamine uptake stimulant | 0.418 0.011 DBMET00259 0.449 0.007 DBMET00260 | ||
| 0.469 | 0.005 | 0.469 | Nav1.2 sodium channel blocker | 0.314 0.013 DBMET00259 0.346 0.01 DBMET00260 | ||
| 0.492 | 0.035 | 0.492 | Immunosuppressant | 0.474 0.04 DBMET00259 0.492 0.035 DBMET00260 | ||
| 0.433 | 0.009 | 0.433 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.331 0.03 DBMET00259 0.393 0.016 DBMET00260 | ||
| 0.415 | 0.009 | 0.415 | Protein kinase C nu inhibitor | 0.286 0.027 DBMET00259 0.376 0.013 DBMET00260 | ||
| 0.449 | 0.05 | 0.478 | Histamine release inhibitor | 0.402 0.075 DBMET00259 0.478 0.037 DBMET00260 | DBMET00260 | |
| 0.45 | 0.053 | 0.581 | Transcription factor NF kappa B inhibitor | 0.539 0.039 DBMET00259 0.581 0.034 DBMET00260 | DBMET00260 | |
| 0.409 | 0.016 | 0.409 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.222 0.066 DBMET00259 0.353 0.027 DBMET00260 | ||
| 0.388 | 0.007 | 0.388 | Ca2+/calmodulin-dependent kinase II delta inhibitor | 0.242 0.034 DBMET00259 0.327 0.013 DBMET00260 | ||
| 0.427 | 0.047 | 0.46 | Vasodilator, peripheral | 0.458 0.038 DBMET00259 0.46 0.038 DBMET00260 | DBMET00260 | |
| 0.398 | 0.027 | 0.482 | Superoxide dismutase inhibitor | 0.26 0.069 DBMET00259 0.482 0.015 DBMET00260 | DBMET00260 | |
| 0.376 | 0.024 | 0.56 | Peroxidase inhibitor | 0.245 0.048 DBMET00259 0.56 0.005 DBMET00260 | DBMET00260 | |
| 0.365 | 0.013 | 0.455 | Tyrosine 3 hydroxylase inhibitor | 0.3 0.033 DBMET00259 0.455 0.005 DBMET00260 | DBMET00260 | |
| 0.344 | 0.009 | 0.373 | Anesthetic local | 0.373 0.008 DBMET00259 0.291 0.013 DBMET00260 | DBMET00259 | |
| 0.387 | 0.066 | 0.445 | Toll-Like receptor agonist | 0.445 0.045 DBMET00259 0.37 0.072 DBMET00260 | DBMET00259 | |
| 0.361 | 0.05 | 0.381 | Vasodilator, coronary | 0.354 0.053 DBMET00259 0.381 0.042 DBMET00260 | DBMET00260 | |
| 0.335 | 0.033 | 0.449 | Interleukin agonist | 0.449 0.013 DBMET00259 0.349 0.029 DBMET00260 | DBMET00259 | |
| 0.336 | 0.034 | 0.342 | Psychostimulant | 0.277 0.049 DBMET00259 0.342 0.033 DBMET00260 | DBMET00260 | |
| 0.325 | 0.026 | 0.325 | CDC-like kinase 2 inhibitor | 0.176 0.079 DBMET00259 0.258 0.043 DBMET00260 | ||
| 0.398 | 0.102 | 0.398 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.299 | 0.004 | 0.299 | Protein kinase B alpha inhibitor | 0.187 0.005 DBMET00259 0.215 0.005 DBMET00260 | ||
| 0.346 | 0.054 | 0.425 | Spasmolytic | 0.425 0.035 DBMET00259 0.389 0.042 DBMET00260 | DBMET00259 | |
| 0.365 | 0.075 | 0.419 | Toll-Like receptor 7 agonist | 0.419 0.053 DBMET00259 0.353 0.08 DBMET00260 | DBMET00259 | |
| 0.292 | 0.005 | 0.292 | 5 Hydroxytryptamine 3E antagonist | 0.207 0.052 DBMET00259 0.22 0.036 DBMET00260 | ||
| 0.377 | 0.094 | 0.377 | Analgesic | 0.227 0.206 DBMET00259 0.356 0.105 DBMET00260 | ||
| 0.297 | 0.034 | 0.328 | Anesthetic general | 0.259 0.047 DBMET00259 0.328 0.027 DBMET00260 | DBMET00260 | |
| 0.292 | 0.031 | 0.292 | TRKC antagonist | 0.176 0.082 DBMET00259 0.252 0.047 DBMET00260 | ||
| 0.321 | 0.073 | 0.395 | Immunostimulant | 0.395 0.051 DBMET00259 0.382 0.055 DBMET00260 | DBMET00259 | |
| 0.263 | 0.017 | 0.263 | Ribosomal protein S6 kinase inhibitor | 0.17 0.052 DBMET00259 0.23 0.026 DBMET00260 | ||
| 0.266 | 0.023 | 0.295 | Nitric-oxide synthase stimulant | 0.268 0.022 DBMET00259 0.295 0.013 DBMET00260 | DBMET00260 | |
| 0.369 | 0.131 | 0.441 | Caspase 9 stimulant | 0.393 0.115 DBMET00259 0.441 0.088 DBMET00260 | DBMET00260 | |
| 0.318 | 0.08 | 0.403 | Cholesterol antagonist | 0.403 0.049 DBMET00259 0.378 0.055 DBMET00260 | DBMET00259 | |
| 0.245 | 0.009 | 0.245 | Protein kinase A inhibitor | 0.148 0.025 DBMET00259 0.216 0.012 DBMET00260 | ||
| 0.273 | 0.039 | 0.335 | RNA-directed DNA polymerase inhibitor | 0.284 0.035 DBMET00259 0.335 0.026 DBMET00260 | DBMET00260 | |
| 0.253 | 0.022 | 0.309 | Alpha-N-acetylglucosaminidase inhibitor | 0.309 0.015 DBMET00259 0.255 0.022 DBMET00260 | DBMET00259 | |
| 0.327 | 0.099 | 0.36 | GABA C receptor rho-3 antagonist | 0.36 0.08 DBMET00260 | DBMET00260 | |
| 0.345 | 0.121 | 0.456 | Calcium channel L-type activator | 0.456 0.047 DBMET00259 0.395 0.085 DBMET00260 | DBMET00259 | |
| 0.254 | 0.032 | 0.284 | Insulin sensitizer | 0.284 0.02 DBMET00259 0.269 0.025 DBMET00260 | DBMET00259 | |
| 0.236 | 0.013 | 0.236 | Nav1.1 sodium channel blocker | 0.215 0.016 DBMET00259 0.208 0.017 DBMET00260 | ||
| 0.224 | 0.004 | 0.224 | Protein kinase C iota inhibitor | 0.157 0.008 DBMET00259 0.183 0.005 DBMET00260 | ||
| 0.269 | 0.05 | 0.269 | Anticonvulsant | 0.189 0.092 DBMET00259 0.148 0.131 DBMET00260 | ||
| 0.221 | 0.006 | 0.221 | Sphingosine 1-phosphate receptor 4 antagonist | 0.216 0.007 DBMET00259 0.192 0.01 DBMET00260 | ||
| 0.284 | 0.069 | 0.296 | Insulysin inhibitor | 0.219 0.131 DBMET00259 0.296 0.061 DBMET00260 | DBMET00260 | |
| 0.227 | 0.013 | 0.227 | Nav1.4 sodium channel blocker | 0.214 0.016 DBMET00259 0.224 0.014 DBMET00260 | ||
| 0.268 | 0.056 | 0.367 | DNA synthesis inhibitor | 0.367 0.027 DBMET00259 0.305 0.042 DBMET00260 | DBMET00259 | |
| 0.216 | 0.006 | 0.216 | Sphingosine 1-phosphate receptor 5 antagonist | 0.19 0.016 DBMET00259 0.21 0.008 DBMET00260 | ||
| 0.299 | 0.093 | 0.299 | Calcium channel activator | 0.242 0.157 DBMET00259 0.28 0.113 DBMET00260 | ||
| 0.267 | 0.061 | 0.267 | Gastrin inhibitor | 0.222 0.117 DBMET00259 0.219 0.12 DBMET00260 | ||
| 0.205 | 0.006 | 0.208 | Sphingosine 1-phosphate receptor 2 antagonist | 0.194 0.009 DBMET00259 0.208 0.006 DBMET00260 | DBMET00260 | |
| 0.29 | 0.095 | 0.376 | Antithrombotic | 0.376 0.056 DBMET00259 0.321 0.076 DBMET00260 | DBMET00259 | |
| 0.199 | 0.013 | 0.278 | Mucolytic | 0.278 0.005 DBMET00259 0.23 0.008 DBMET00260 | DBMET00259 | |
| 0.275 | 0.093 | 0.471 | Interleukin 2 agonist | 0.471 0.012 DBMET00259 0.326 0.057 DBMET00260 | DBMET00259 | |
| 0.25 | 0.069 | 0.294 | Vasodilator | 0.253 0.067 DBMET00259 0.294 0.05 DBMET00260 | DBMET00260 | |
| 0.323 | 0.143 | 0.44 | Cyclophilin D inhibitor | 0.44 0.071 DBMET00259 0.378 0.104 DBMET00260 | DBMET00259 | |
| 0.192 | 0.014 | 0.192 | Nav1.5 sodium channel blocker | 0.156 0.024 DBMET00259 0.142 0.032 DBMET00260 | ||
| 0.197 | 0.021 | 0.298 | Expectorant | 0.298 0.009 DBMET00259 0.245 0.013 DBMET00260 | DBMET00259 | |
| 0.277 | 0.102 | 0.335 | Apoptosis antagonist | 0.318 0.074 DBMET00259 0.335 0.064 DBMET00260 | DBMET00260 | |
| 0.189 | 0.018 | 0.26 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.26 0.009 DBMET00259 0.141 0.03 DBMET00260 | DBMET00259 | |
| 0.192 | 0.022 | 0.192 | Nav1.6 sodium channel blocker | 0.131 0.079 DBMET00259 0.168 0.036 DBMET00260 | ||
| 0.258 | 0.089 | 0.258 | Ca(v)3.3 blocker | |||
| 0.207 | 0.043 | 0.207 | Protein kinase (CK1) gamma 3 inhibitor | 0.182 0.059 DBMET00260 | ||
| 0.18 | 0.019 | 0.207 | Vanilloid 1 agonist | 0.182 0.018 DBMET00259 0.207 0.01 DBMET00260 | DBMET00260 | |
| 0.22 | 0.059 | 0.269 | Neurotrophic factor enhancer | 0.256 0.035 DBMET00259 0.269 0.029 DBMET00260 | DBMET00260 | |
| 0.177 | 0.02 | 0.19 | Catalase inhibitor | 0.15 0.026 DBMET00259 0.19 0.017 DBMET00260 | DBMET00260 | |
| 0.184 | 0.028 | 0.184 | Cathepsin H inhibitor | 0.144 0.051 DBMET00259 0.14 0.054 DBMET00260 | ||
| 0.196 | 0.044 | 0.212 | Phospholipase A2 inhibitor | 0.203 0.041 DBMET00259 0.212 0.037 DBMET00260 | DBMET00260 | |
| 0.179 | 0.027 | 0.179 | Aminopeptidase B inhibitor | 0.162 0.033 DBMET00259 0.177 0.028 DBMET00260 | ||
| 0.217 | 0.066 | 0.217 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.19 0.084 DBMET00260 | ||
| 0.186 | 0.035 | 0.186 | Sodium channel (voltage-gated) blocker | 0.133 0.069 DBMET00259 0.113 0.093 DBMET00260 | ||
| 0.155 | 0.004 | 0.155 | Sphingosine 1-phosphate receptor 3 agonist | 0.127 0.005 DBMET00259 0.132 0.005 DBMET00260 | ||
| 0.223 | 0.073 | 0.263 | Peptidyltransferase inhibitor | 0.208 0.089 DBMET00259 0.263 0.042 DBMET00260 | DBMET00260 | |
| 0.206 | 0.056 | 0.213 | Growth hormone agonist | 0.169 0.074 DBMET00259 0.213 0.054 DBMET00260 | DBMET00260 | |
| 0.313 | 0.163 | 0.427 | Apoptosis agonist | 0.346 0.141 DBMET00259 0.427 0.101 DBMET00260 | DBMET00260 | |
| 0.192 | 0.044 | 0.254 | Interferon gamma antagonist | 0.193 0.044 DBMET00259 0.254 0.028 DBMET00260 | DBMET00260 | |
| 0.185 | 0.038 | 0.185 | Sodium channel blocker | 0.117 0.088 DBMET00259 0.109 0.099 DBMET00260 | ||
| 0.159 | 0.018 | 0.159 | Protein kinase C delta inhibitor | 0.141 0.025 DBMET00259 0.159 0.018 DBMET00260 | ||
| 0.207 | 0.067 | 0.274 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.214 0.062 DBMET00259 0.274 0.032 DBMET00260 | DBMET00260 | |
| 0.231 | 0.092 | 0.298 | DNA damaging | 0.298 0.058 DBMET00259 0.245 0.083 DBMET00260 | DBMET00259 | |
| 0.192 | 0.055 | 0.208 | Succinate dehydrogenase inhibitor | 0.17 0.08 DBMET00259 0.208 0.043 DBMET00260 | DBMET00260 | |
| 0.171 | 0.034 | 0.2 | Adenylate cyclase stimulant | 0.194 0.016 DBMET00259 0.2 0.013 DBMET00260 | DBMET00260 | |
| 0.15 | 0.016 | 0.15 | Protein kinase B gamma inhibitor | 0.079 0.047 DBMET00259 0.094 0.036 DBMET00260 | ||
| 0.151 | 0.019 | 0.167 | Aminoacyl-tRNA synthetase inhibitor | 0.167 0.015 DBMET00259 0.158 0.017 DBMET00260 | DBMET00259 | |
| 0.143 | 0.012 | 0.201 | Vanilloid agonist | 0.123 0.017 DBMET00259 0.201 0.007 DBMET00260 | DBMET00260 | |
| 0.152 | 0.023 | 0.213 | Creatine kinase inhibitor | 0.116 0.044 DBMET00259 0.213 0.009 DBMET00260 | DBMET00260 | |
| 0.165 | 0.039 | 0.165 | Nav1.3 sodium channel blocker | 0.102 0.095 DBMET00259 0.114 0.081 DBMET00260 | ||
| 0.129 | 0.004 | 0.129 | Somatostatin 5 agonist | 0.078 0.007 DBMET00259 0.096 0.005 DBMET00260 | ||
| 0.156 | 0.031 | 0.157 | Ca2+-transporting ATPase inhibitor | 0.147 0.05 DBMET00259 0.157 0.029 DBMET00260 | DBMET00260 | |
| 0.134 | 0.01 | 0.134 | Protein kinase B beta inhibitor | 0.106 0.022 DBMET00259 0.099 0.026 DBMET00260 | ||
| 0.133 | 0.009 | 0.149 | Glycine receptor agonist | 0.099 0.022 DBMET00259 0.149 0.007 DBMET00260 | DBMET00260 | |
| 0.128 | 0.008 | 0.128 | 5 Hydroxytryptamine 2A agonist | 0.087 0.022 DBMET00259 0.126 0.008 DBMET00260 | ||
| 0.16 | 0.042 | 0.211 | Aldehyde dehydrogenase inhibitor | 0.176 0.035 DBMET00259 0.211 0.025 DBMET00260 | DBMET00260 | |
| 0.179 | 0.062 | 0.224 | Phospholipase C inhibitor | 0.187 0.054 DBMET00259 0.224 0.032 DBMET00260 | DBMET00260 | |
| 0.178 | 0.061 | 0.194 | ATPase inhibitor | 0.194 0.043 DBMET00260 | DBMET00260 | |
| 0.131 | 0.016 | 0.131 | Aminopeptidase I inhibitor | 0.11 0.023 DBMET00259 0.127 0.018 DBMET00260 | ||
| 0.13 | 0.016 | 0.223 | Phenylalanine 4-hydroxylase inhibitor | 0.098 0.027 DBMET00259 0.223 0.005 DBMET00260 | DBMET00260 | |
| 0.128 | 0.014 | 0.128 | Sphingosine 1-phosphate receptor 4 agonist | 0.109 0.021 DBMET00259 0.107 0.022 DBMET00260 | ||
| 0.169 | 0.056 | 0.29 | Lipid peroxidase inhibitor | 0.197 0.043 DBMET00259 0.29 0.02 DBMET00260 | DBMET00260 | |
| 0.141 | 0.03 | 0.141 | Adenylate kinase inhibitor | 0.133 0.034 DBMET00259 0.137 0.032 DBMET00260 | ||
| 0.124 | 0.013 | 0.124 | Granulocyte macrophage colony stimulating factor agonist | 0.116 0.019 DBMET00259 0.112 0.022 DBMET00260 | ||
| 0.169 | 0.059 | 0.169 | Acetylcholine M1 receptor antagonist | 0.149 0.075 DBMET00259 0.162 0.064 DBMET00260 | ||
| 0.116 | 0.006 | 0.116 | Glutamate (mGluR6) antagonist | 0.106 0.008 DBMET00259 0.104 0.009 DBMET00260 | ||
| 0.172 | 0.062 | 0.183 | Interleukin 6 antagonist | 0.183 0.053 DBMET00260 | DBMET00260 | |
| 0.202 | 0.094 | 0.3 | Angiogenesis stimulant | 0.3 0.049 DBMET00259 0.287 0.054 DBMET00260 | DBMET00259 | |
| 0.12 | 0.014 | 0.12 | MAP3K7 inhibitor | 0.094 0.026 DBMET00259 0.111 0.017 DBMET00260 | ||
| 0.144 | 0.04 | 0.144 | Ferrochelatase inhibitor | 0.095 0.076 DBMET00259 0.099 0.071 DBMET00260 | ||
| 0.127 | 0.024 | 0.127 | CYP2A6 inhibitor | 0.078 0.05 DBMET00260 | ||
| 0.167 | 0.067 | 0.186 | Neurotensin receptor agonist | 0.144 0.117 DBMET00259 0.186 0.044 DBMET00260 | DBMET00260 | |
| 0.151 | 0.052 | 0.151 | Protein kinase (CK1) delta inhibitor | 0.106 0.086 DBMET00260 | ||
| 0.16 | 0.061 | 0.16 | Protein kinase (CK1) gamma 1 inhibitor | 0.131 0.086 DBMET00260 | ||
| 0.157 | 0.059 | 0.157 | Mannose-6-phosphate isomerase inhibitor | 0.156 0.059 DBMET00259 0.154 0.061 DBMET00260 | ||
| 0.15 | 0.052 | 0.207 | Farnesoid X receptor antagonist | 0.144 0.059 DBMET00259 0.207 0.02 DBMET00260 | DBMET00260 | |
| 0.128 | 0.031 | 0.128 | Calcium antagonist | |||
| 0.102 | 0.005 | 0.102 | Potassium channel subfamily K member 3 blocker | 0.031 0.02 DBMET00259 0.042 0.014 DBMET00260 | ||
| 0.212 | 0.119 | 0.224 | Transcription factor STAT3 inhibitor | 0.224 0.107 DBMET00260 | DBMET00260 | |
| 0.11 | 0.017 | 0.11 | Argininosuccinate synthase inhibitor | 0.1 0.019 DBMET00259 0.097 0.02 DBMET00260 | ||
| 0.117 | 0.024 | 0.119 | Glutathione S-transferase inhibitor | 0.113 0.027 DBMET00259 0.119 0.023 DBMET00260 | DBMET00260 | |
| 0.217 | 0.124 | 0.322 | Lipoxygenase inhibitor | 0.206 0.134 DBMET00259 0.322 0.061 DBMET00260 | DBMET00260 | |
| 0.126 | 0.035 | 0.126 | Nitric-oxide synthase inhibitor | 0.1 0.06 DBMET00260 | ||
| 0.115 | 0.024 | 0.117 | Glutamate dehydrogenase inhibitor | 0.11 0.026 DBMET00259 0.117 0.024 DBMET00260 | DBMET00260 | |
| 0.125 | 0.035 | 0.168 | Prolactin inhibitor | 0.123 0.036 DBMET00259 0.168 0.016 DBMET00260 | DBMET00260 | |
| 0.117 | 0.028 | 0.127 | Ornithine decarboxylase inhibitor | 0.12 0.026 DBMET00259 0.127 0.021 DBMET00260 | DBMET00260 | |
| 0.128 | 0.038 | 0.144 | UDP-glucose 4-epimerase inhibitor | 0.144 0.031 DBMET00259 0.134 0.035 DBMET00260 | DBMET00259 | |
| 0.11 | 0.022 | 0.176 | Interferon agonist | 0.176 0.008 DBMET00259 0.1 0.029 DBMET00260 | DBMET00259 | |
| 0.094 | 0.006 | 0.124 | Sphingosine 1-phosphate receptor agonist | 0.124 0.004 DBMET00259 0.075 0.01 DBMET00260 | DBMET00259 | |
| 0.12 | 0.032 | 0.136 | Triose-phosphate isomerase inhibitor | 0.136 0.025 DBMET00259 0.105 0.043 DBMET00260 | DBMET00259 | |
| 0.096 | 0.009 | 0.096 | Sphingosine 1-phosphate receptor 3 antagonist | 0.085 0.014 DBMET00259 0.09 0.011 DBMET00260 | ||
| 0.097 | 0.01 | 0.097 | Potassium channel (Tandem pore domain) blocker | 0.069 0.067 DBMET00259 0.076 0.045 DBMET00260 | ||
| 0.111 | 0.024 | 0.179 | Glutamate decarboxylase inhibitor | 0.091 0.035 DBMET00259 0.179 0.009 DBMET00260 | DBMET00260 | |
| 0.134 | 0.048 | 0.245 | Cystathionine beta-synthase inhibitor | 0.097 0.08 DBMET00259 0.245 0.016 DBMET00260 | DBMET00260 | |
| 0.113 | 0.027 | 0.278 | Histidine decarboxylase inhibitor | 0.278 0.007 DBMET00259 0.234 0.01 DBMET00260 | DBMET00259 | |
| 0.12 | 0.035 | 0.12 | MAP kinase kinase 1 inhibitor | 0.094 0.065 DBMET00259 0.111 0.044 DBMET00260 | ||
| 0.125 | 0.04 | 0.177 | DOPA decarboxylase inhibitor | 0.108 0.062 DBMET00259 0.177 0.011 DBMET00260 | DBMET00260 | |
| 0.101 | 0.017 | 0.101 | Urokinase inhibitor | 0.069 0.024 DBMET00259 0.082 0.021 DBMET00260 | ||
| 0.089 | 0.005 | 0.112 | Sphingosine 1-phosphate receptor 1 agonist | 0.112 0.004 DBMET00259 0.075 0.007 DBMET00260 | DBMET00259 | |
| 0.122 | 0.038 | 0.143 | Anabolic | 0.134 0.028 DBMET00259 0.143 0.022 DBMET00260 | DBMET00260 | |
| 0.14 | 0.057 | 0.147 | Cyclooxygenase 3 inhibitor | 0.108 0.092 DBMET00259 0.147 0.051 DBMET00260 | DBMET00260 | |
| 0.201 | 0.118 | 0.201 | Neuropeptide Y2 antagonist | 0.187 0.144 DBMET00260 | ||
| 0.17 | 0.087 | 0.239 | DNA methyltransferase I inhibitor | 0.133 0.126 DBMET00259 0.239 0.052 DBMET00260 | DBMET00260 | |
| 0.129 | 0.047 | 0.139 | Photosensitizer | 0.131 0.045 DBMET00259 0.139 0.038 DBMET00260 | DBMET00260 | |
| 0.147 | 0.065 | 0.147 | Cytokine production inhibitor | 0.11 0.1 DBMET00260 | ||
| 0.116 | 0.034 | 0.116 | Glutamate (mGluR7) agonist | |||
| 0.132 | 0.05 | 0.132 | 5 Hydroxytryptamine 2B antagonist | 0.099 0.084 DBMET00260 | ||
| 0.114 | 0.034 | 0.114 | Histamine N-methyltransferase inhibitor | 0.097 0.049 DBMET00260 | ||
| 0.1 | 0.02 | 0.109 | Carbamoyl phosphate synthetase inhibitor | 0.098 0.021 DBMET00259 0.109 0.018 DBMET00260 | DBMET00260 | |
| 0.155 | 0.075 | 0.213 | Melanin inhibitor | 0.153 0.078 DBMET00259 0.213 0.036 DBMET00260 | DBMET00260 | |
| 0.112 | 0.033 | 0.124 | NADH dehydrogenase inhibitor | 0.124 0.026 DBMET00259 0.123 0.027 DBMET00260 | DBMET00259 | |
| 0.108 | 0.032 | 0.113 | Glutamate release inhibitor | 0.113 0.027 DBMET00259 0.091 0.059 DBMET00260 | DBMET00259 | |
| 0.088 | 0.012 | 0.088 | 5 Hydroxytryptamine 2 agonist | 0.047 0.041 DBMET00259 0.06 0.027 DBMET00260 | ||
| 0.117 | 0.042 | 0.117 | Factor V inhibitor | 0.105 0.059 DBMET00259 0.106 0.056 DBMET00260 | ||
| 0.137 | 0.062 | 0.196 | Toll-Like receptor 2 antagonist | 0.156 0.049 DBMET00259 0.196 0.026 DBMET00260 | DBMET00260 | |
| 0.121 | 0.046 | 0.158 | Carbonic anhydrase XV inhibitor | 0.154 0.029 DBMET00259 0.158 0.028 DBMET00260 | DBMET00260 | |
| 0.104 | 0.028 | 0.167 | Keratolytic | 0.116 0.023 DBMET00259 0.167 0.012 DBMET00260 | DBMET00260 | |
| 0.12 | 0.045 | 0.187 | Carbonic anhydrase III inhibitor | 0.135 0.035 DBMET00259 0.187 0.018 DBMET00260 | DBMET00260 | |
| 0.164 | 0.09 | 0.164 | CDC-like kinase 4 inhibitor | |||
| 0.172 | 0.099 | 0.222 | DNA methylase inhibitor | 0.222 0.065 DBMET00260 | DBMET00260 | |
| 0.104 | 0.033 | 0.104 | Inducible nitric-oxide synthase inhibitor | 0.09 0.047 DBMET00260 | ||
| 0.141 | 0.071 | 0.15 | Heat shock protein 70 antagonist | 0.15 0.046 DBMET00260 | DBMET00260 | |
| 0.106 | 0.036 | 0.106 | Acetylcholine nicotinic antagonist | 0.073 0.063 DBMET00259 0.087 0.048 DBMET00260 | ||
| 0.192 | 0.121 | 0.192 | Calpain inhibitor | |||
| 0.088 | 0.018 | 0.126 | Interferon inducer | 0.126 0.006 DBMET00259 0.081 0.023 DBMET00260 | DBMET00259 | |
| 0.17 | 0.101 | 0.17 | Focal adhesion kinase 2 inhibitor | |||
| 0.092 | 0.023 | 0.092 | Secretase beta inhibitor | 0.081 0.035 DBMET00260 | ||
| 0.096 | 0.03 | 0.117 | Estrogen-related receptor beta agonist | 0.082 0.061 DBMET00259 0.117 0.011 DBMET00260 | DBMET00260 | |
| 0.086 | 0.023 | 0.086 | Protease 3C (Human rhinovirus) inhibitor | 0.066 0.042 DBMET00259 0.068 0.039 DBMET00260 | ||
| 0.13 | 0.067 | 0.13 | Antibacterial (Helicobacter pylori) | 0.129 0.068 DBMET00260 | ||
| 0.101 | 0.038 | 0.137 | Transcription factor NF kappa B stimulant | 0.137 0.019 DBMET00259 0.104 0.035 DBMET00260 | DBMET00259 | |
| 0.151 | 0.088 | 0.163 | Arachidonic acid antagonist | 0.163 0.073 DBMET00260 | DBMET00260 | |
| 0.245 | 0.182 | 0.332 | Antibacterial | 0.276 0.154 DBMET00259 0.332 0.113 DBMET00260 | DBMET00260 | |
| 0.141 | 0.079 | 0.141 | Neuropeptide Y1 antagonist | 0.123 0.116 DBMET00259 0.138 0.085 DBMET00260 | ||
| 0.121 | 0.059 | 0.125 | Microtubule formation inhibitor | 0.109 0.075 DBMET00259 0.125 0.055 DBMET00260 | DBMET00260 | |
| 0.199 | 0.139 | 0.21 | Transcription factor STAT inhibitor | 0.21 0.124 DBMET00260 | DBMET00260 | |
| 0.066 | 0.007 | 0.066 | 5 Hydroxytryptamine 2B agonist | 0.042 0.022 DBMET00260 | ||
| 0.083 | 0.025 | 0.112 | Beta adrenoreceptor antagonist | 0.104 0.015 DBMET00259 0.112 0.012 DBMET00260 | DBMET00260 | |
| 0.104 | 0.046 | 0.131 | Protein kinase C zeta inhibitor | 0.095 0.057 DBMET00259 0.131 0.026 DBMET00260 | DBMET00260 | |
| 0.095 | 0.038 | 0.106 | Somatostatin 1 agonist | 0.105 0.031 DBMET00259 0.106 0.03 DBMET00260 | DBMET00260 | |
| 0.115 | 0.058 | 0.126 | GABA C receptor antagonist | 0.126 0.047 DBMET00260 | DBMET00260 | |
| 0.112 | 0.056 | 0.125 | GABA C receptor agonist | 0.089 0.08 DBMET00259 0.125 0.046 DBMET00260 | DBMET00260 | |
| 0.086 | 0.031 | 0.086 | Neuronal nicotinic receptor antagonist | 0.058 0.057 DBMET00259 0.072 0.043 DBMET00260 | ||
| 0.077 | 0.023 | 0.077 | Ornithine carbamoyltransferase inhibitor | 0.072 0.025 DBMET00259 0.073 0.024 DBMET00260 | ||
| 0.073 | 0.02 | 0.083 | Sphingosine kinase 2 inhibitor | 0.079 0.016 DBMET00259 0.083 0.014 DBMET00260 | DBMET00260 | |
| 0.116 | 0.064 | 0.223 | Monophenol monooxygenase inhibitor | 0.137 0.052 DBMET00259 0.223 0.028 DBMET00260 | DBMET00260 | |
| 0.079 | 0.029 | 0.079 | Glutamate (mGluR7) antagonist | 0.064 0.055 DBMET00260 | ||
| 0.136 | 0.086 | 0.136 | Thiol protease inhibitor | |||
| 0.061 | 0.011 | 0.061 | Plasmepsin II inhibitor | 0.059 0.012 DBMET00259 0.049 0.019 DBMET00260 | ||
| 0.061 | 0.012 | 0.072 | Cytokine production stimulant | 0.072 0.006 DBMET00259 0.05 0.03 DBMET00260 | DBMET00259 | |
| 0.099 | 0.051 | 0.113 | Bile acid receptor antagonist | 0.094 0.063 DBMET00259 0.113 0.028 DBMET00260 | DBMET00260 | |
| 0.086 | 0.038 | 0.107 | Phosphofructokinase-1 inhibitor | 0.104 0.03 DBMET00259 0.107 0.029 DBMET00260 | DBMET00260 | |
| 0.083 | 0.035 | 0.102 | Selectin antagonist | 0.102 0.027 DBMET00259 0.095 0.029 DBMET00260 | DBMET00259 | |
| 0.12 | 0.073 | 0.12 | Cholinergic antagonist | 0.111 0.083 DBMET00259 0.114 0.08 DBMET00260 | ||
| 0.086 | 0.04 | 0.103 | GABA aminotransferase inhibitor | 0.073 0.056 DBMET00259 0.103 0.025 DBMET00260 | DBMET00260 | |
| 0.201 | 0.156 | 0.201 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.201 0.156 DBMET00260 | ||
| 0.077 | 0.031 | 0.079 | Potassium channel (ATP-sensitive) blocker | 0.079 0.029 DBMET00259 0.065 0.05 DBMET00260 | DBMET00259 | |
| 0.106 | 0.06 | 0.13 | Toll-Like receptor 4 antagonist | 0.108 0.057 DBMET00259 0.13 0.034 DBMET00260 | DBMET00260 | |
| 0.116 | 0.071 | 0.118 | Beta amyloid protein antagonist | 0.118 0.069 DBMET00260 | DBMET00260 | |
| 0.081 | 0.036 | 0.081 | S-adenosyl-L-methionine decarboxylase inhibitor | |||
| 0.098 | 0.053 | 0.098 | Toll-Like receptor 3 antagonist | |||
| 0.051 | 0.008 | 0.051 | Lysophosphatidic acid 2 receptor antagonist | 0.029 0.024 DBMET00259 0.044 0.01 DBMET00260 | ||
| 0.128 | 0.085 | 0.128 | Protein kinase (CK1) inhibitor | |||
| 0.048 | 0.005 | 0.062 | Glutamate (mGluR3) agonist | 0.047 0.006 DBMET00259 0.062 0.004 DBMET00260 | DBMET00260 | |
| 0.177 | 0.135 | 0.361 | Antioxidant | 0.249 0.084 DBMET00259 0.361 0.044 DBMET00260 | DBMET00260 | |
| 0.122 | 0.08 | 0.228 | Amylase inhibitor | 0.208 0.042 DBMET00259 0.228 0.035 DBMET00260 | DBMET00260 | |
| 0.112 | 0.072 | 0.112 | Proteasome inhibitor | 0.101 0.085 DBMET00259 0.107 0.078 DBMET00260 | ||
| 0.126 | 0.086 | 0.187 | Protein kinase stimulant | 0.187 0.047 DBMET00259 0.181 0.049 DBMET00260 | DBMET00259 | |
| 0.071 | 0.031 | 0.071 | Biliverdin reductase inhibitor | 0.063 0.037 DBMET00259 0.063 0.038 DBMET00260 | ||
| 0.063 | 0.023 | 0.127 | Adenine nucleotide translocase inhibitor | 0.127 0.003 DBMET00259 0.074 0.012 DBMET00260 | DBMET00259 | |
| 0.063 | 0.024 | 0.065 | Sphingosine 1-phosphate receptor 1 antagonist | 0.065 0.023 DBMET00259 0.062 0.025 DBMET00260 | DBMET00259 | |
| 0.055 | 0.016 | 0.055 | Glutamate (mGluR4) antagonist | |||
| 0.114 | 0.076 | 0.114 | Acetylcholine antagonist | 0.105 0.086 DBMET00259 0.108 0.082 DBMET00260 | ||
| 0.081 | 0.043 | 0.118 | Cathepsin G inhibitor | 0.118 0.027 DBMET00259 0.072 0.052 DBMET00260 | DBMET00259 | |
| 0.067 | 0.029 | 0.078 | Sphingosine kinase inhibitor | 0.071 0.024 DBMET00259 0.078 0.017 DBMET00260 | DBMET00260 | |
| 0.054 | 0.017 | 0.054 | Glutamate (mGluR group III) antagonist | 0.041 0.036 DBMET00260 | ||
| 0.081 | 0.044 | 0.081 | Sphingosine 1-phosphate receptor antagonist | 0.078 0.05 DBMET00259 0.078 0.049 DBMET00260 | ||
| 0.1 | 0.063 | 0.1 | GABA C receptor rho-1 antagonist | 0.1 0.062 DBMET00260 | ||
| 0.067 | 0.031 | 0.127 | Alcohol oxidase inhibitor | 0.127 0.013 DBMET00260 | DBMET00260 | |
| 0.05 | 0.015 | 0.062 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.043 0.026 DBMET00259 0.062 0.006 DBMET00260 | DBMET00260 | |
| 0.048 | 0.013 | 0.049 | Glutamate (mGluR8) agonist | 0.046 0.014 DBMET00259 0.049 0.012 DBMET00260 | DBMET00260 | |
| 0.059 | 0.024 | 0.059 | Lysophosphatidic acid 3 receptor antagonist | 0.051 0.034 DBMET00259 0.049 0.037 DBMET00260 | ||
| 0.102 | 0.068 | 0.121 | Mediator release inhibitor | 0.121 0.046 DBMET00260 | DBMET00260 | |
| 0.109 | 0.075 | 0.109 | Protein kinase (CK1) gamma 2 inhibitor | |||
| 0.049 | 0.015 | 0.049 | Kainate receptor agonist | 0.042 0.027 DBMET00259 0.047 0.018 DBMET00260 | ||
| 0.039 | 0.006 | 0.039 | Glutamate (mGluR1a) agonist | 0.021 0.017 DBMET00259 0.03 0.009 DBMET00260 | ||
| 0.14 | 0.108 | 0.14 | LIM domain kinase 1 inhibitor | |||
| 0.057 | 0.027 | 0.077 | Beta 2 adrenoreceptor antagonist | 0.07 0.017 DBMET00259 0.077 0.013 DBMET00260 | DBMET00260 | |
| 0.084 | 0.053 | 0.16 | Adrenaline agonist | 0.16 0.012 DBMET00259 0.128 0.022 DBMET00260 | DBMET00259 | |
| 0.063 | 0.033 | 0.079 | Beta 1 adrenoreceptor antagonist | 0.074 0.023 DBMET00259 0.079 0.019 DBMET00260 | DBMET00260 | |
| 0.056 | 0.027 | 0.076 | Glycine transporter 2 inhibitor | 0.076 0.019 DBMET00260 | DBMET00260 | |
| 0.046 | 0.018 | 0.046 | Diamine oxidase inhibitor | |||
| 0.044 | 0.016 | 0.048 | Somatostatin 5 antagonist | 0.03 0.024 DBMET00259 0.048 0.014 DBMET00260 | DBMET00260 | |
| 0.076 | 0.05 | 0.127 | Porphobilinogen synthase inhibitor | 0.127 0.026 DBMET00259 0.093 0.039 DBMET00260 | DBMET00259 | |
| 0.075 | 0.05 | 0.075 | Vanilloid 4 agonist | 0.071 0.062 DBMET00259 | ||
| 0.093 | 0.068 | 0.093 | Sphingomyelinase inhibitor | |||
| 0.047 | 0.022 | 0.047 | Somatostatin 1 antagonist | 0.038 0.027 DBMET00259 0.047 0.022 DBMET00260 | ||
| 0.065 | 0.04 | 0.065 | Calcium channel P-type blocker | |||
| 0.04 | 0.016 | 0.04 | Tryptophan 5 hydroxylase inhibitor | |||
| 0.097 | 0.074 | 0.097 | Falcipain 3 inhibitor | |||
| 0.064 | 0.041 | 0.064 | NMDA receptor agonist | 0.06 0.047 DBMET00260 | ||
| 0.054 | 0.031 | 0.054 | Alpha 1L adrenoreceptor antagonist | 0.049 0.047 DBMET00260 | ||
| 0.105 | 0.083 | 0.157 | Alkylator | 0.157 0.043 DBMET00259 0.133 0.057 DBMET00260 | DBMET00259 | |
| 0.047 | 0.025 | 0.047 | Histamine H2 receptor agonist | |||
| 0.058 | 0.036 | 0.06 | Pregnane X receptor antagonist | 0.06 0.03 DBMET00260 | DBMET00260 | |
| 0.031 | 0.009 | 0.031 | Glutamate (mGluR1) agonist | 0.028 0.012 DBMET00259 0.029 0.01 DBMET00260 | ||
| 0.041 | 0.02 | 0.041 | Glutamate (mGluR3) antagonist | 0.037 0.024 DBMET00259 0.038 0.023 DBMET00260 | ||
| 0.038 | 0.017 | 0.038 | Somatostatin agonist | 0.033 0.02 DBMET00260 | ||
| 0.038 | 0.016 | 0.038 | Adenosine uptake inhibitor | |||
| 0.094 | 0.074 | 0.112 | Urease inhibitor | 0.112 0.053 DBMET00260 | DBMET00260 | |
| 0.06 | 0.04 | 0.06 | Carbonic anhydrase stimulant | 0.055 0.047 DBMET00260 | ||
| 0.046 | 0.026 | 0.046 | Guanylate cyclase inhibitor | 0.045 0.027 DBMET00259 | ||
| 0.105 | 0.085 | 0.105 | Acetylcholine muscarinic antagonist | 0.102 0.089 DBMET00260 | ||
| 0.044 | 0.024 | 0.047 | Sphingosine kinase 1 inhibitor | 0.047 0.019 DBMET00259 0.047 0.02 DBMET00260 | DBMET00260 | |
| 0.093 | 0.074 | 0.093 | Gastric antisecretory | |||
| 0.055 | 0.037 | 0.055 | Immunoglobulin Fc receptor antagonist | |||
| 0.029 | 0.011 | 0.036 | Vanilloid 2 agonist | 0.028 0.013 DBMET00259 0.036 0.005 DBMET00260 | DBMET00260 | |
| 0.124 | 0.106 | 0.155 | Hemostatic | 0.155 0.062 DBMET00259 0.137 0.085 DBMET00260 | DBMET00259 | |
| 0.026 | 0.009 | 0.026 | Isoleucine-tRNA ligase inhibitor | 0.022 0.016 DBMET00259 0.026 0.01 DBMET00260 | ||
| 0.086 | 0.07 | 0.117 | Alcohol dehydrogenase inhibitor | 0.117 0.037 DBMET00260 | DBMET00260 | |
| 0.031 | 0.015 | 0.037 | Estrogen-related receptor gamma antagonist | 0.037 0.006 DBMET00260 | DBMET00260 | |
| 0.076 | 0.06 | 0.089 | MAP kinase kinase 7 inhibitor | 0.073 0.07 DBMET00259 0.089 0.026 DBMET00260 | DBMET00260 | |
| 0.101 | 0.086 | 0.116 | TRPA1 agonist | 0.116 0.063 DBMET00260 | DBMET00260 | |
| 0.037 | 0.022 | 0.037 | Retinoid X alpha receptor agonist | 0.031 0.03 DBMET00259 | ||
| 0.051 | 0.037 | 0.051 | Aconitate hydratase inhibitor | |||
| 0.053 | 0.039 | 0.053 | Acyl-CoA dehydrogenase inhibitor | 0.048 0.044 DBMET00260 | ||
| 0.06 | 0.048 | 0.078 | Beta 2 adrenoreceptor agonist | 0.078 0.011 DBMET00259 0.07 0.019 DBMET00260 | DBMET00259 | |
| 0.042 | 0.03 | 0.053 | Oxytocin agonist | 0.053 0.022 DBMET00260 | DBMET00260 | |
| 0.052 | 0.039 | 0.052 | Nicotinic alpha3beta2 receptor antagonist | |||
| 0.116 | 0.105 | 0.149 | Cell wall synthesis inhibitor | 0.149 0.067 DBMET00259 0.142 0.073 DBMET00260 | DBMET00259 | |
| 0.111 | 0.1 | 0.111 | Protein kinase (CK1) gamma inhibitor | |||
| 0.053 | 0.042 | 0.053 | Epithelial sodium channel blocker | |||
| 0.027 | 0.016 | 0.027 | Methionyl aminopeptidase 2 inhibitor | |||
| 0.041 | 0.03 | 0.041 | Acetyl-CoA carboxylase inhibitor | |||
| 0.052 | 0.041 | 0.052 | Human rhinovirus A protease inhibitor | |||
| 0.079 | 0.069 | 0.079 | Factor XII inhibitor | |||
| 0.044 | 0.034 | 0.044 | Parathyroid hormone antagonist | |||
| 0.199 | 0.189 | 0.199 | Calpain 2 inhibitor | |||
| 0.053 | 0.043 | 0.062 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.062 0.033 DBMET00259 0.054 0.043 DBMET00260 | DBMET00259 | |
| 0.051 | 0.042 | 0.059 | Alpha-mannosidase inhibitor | 0.059 0.028 DBMET00259 0.055 0.034 DBMET00260 | DBMET00259 | |
| 0.104 | 0.095 | 0.104 | Transcription factor STAT6 inhibitor | 0.103 0.098 DBMET00260 | ||
| 0.136 | 0.127 | 0.136 | Clk dual-specificity kinase inhibitor | |||
| 0.125 | 0.116 | 0.125 | GABA C receptor rho-2 antagonist | 0.125 0.116 DBMET00260 | ||
| 0.041 | 0.032 | 0.041 | Leukocyte elastase inhibitor | |||
| 0.136 | 0.128 | 0.136 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.03 | 0.022 | 0.03 | Plasmepsin I inhibitor | |||
| 0.026 | 0.018 | 0.046 | Thyroid hormone agonist | 0.025 0.019 DBMET00259 0.046 0.005 DBMET00260 | DBMET00260 | |
| 0.035 | 0.027 | 0.035 | Glutamate (mGluR8) antagonist | 0.035 0.026 DBMET00259 0.034 0.029 DBMET00260 | ||
| 0.058 | 0.051 | 0.058 | Corticotropin releasing factor 2 receptor antagonist | |||
| 0.053 | 0.046 | 0.053 | Kallikrein 1 inhibitor | |||
| 0.099 | 0.092 | 0.113 | MAO inhibitor | 0.113 0.079 DBMET00260 | DBMET00260 | |
| 0.124 | 0.118 | 0.124 | Pregnane X receptor agonist | |||
| 0.017 | 0.011 | 0.02 | Telomerase stimulant | 0.019 0.009 DBMET00259 0.02 0.007 DBMET00260 | DBMET00260 | |
| 0.051 | 0.045 | 0.059 | Sphingosine 1-phosphate receptor 5 agonist | 0.059 0.026 DBMET00259 | DBMET00259 | |
| 0.094 | 0.089 | 0.114 | Protein kinase C gamma inhibitor | 0.114 0.058 DBMET00260 | DBMET00260 | |
| 0.054 | 0.049 | 0.054 | Leukotriene C antagonist | 0.053 0.051 DBMET00259 0.054 0.046 DBMET00260 | ||
| 0.067 | 0.062 | 0.067 | Peroxisome proliferator-activated receptor gamma antagonist | |||
| 0.153 | 0.148 | 0.167 | Cyclic AMP phosphodiesterase inhibitor | 0.167 0.126 DBMET00260 | DBMET00260 | |
| 0.041 | 0.037 | 0.041 | Histamine H1 receptor agonist | |||
| 0.017 | 0.013 | 0.017 | Tryptophan hydroxylase 1 inhibitor | |||
| 0.025 | 0.022 | 0.03 | Uridine phosphorylase inhibitor | 0.03 0.018 DBMET00259 | DBMET00259 | |
| 0.018 | 0.015 | 0.025 | Estrogen-related receptor gamma agonist | 0.025 0.006 DBMET00260 | DBMET00260 | |
| 0.06 | 0.057 | 0.074 | Beta 3 adrenoreceptor antagonist | 0.074 0.029 DBMET00260 | DBMET00260 | |
| 0.043 | 0.041 | 0.058 | Beta adrenoreceptor agonist | 0.058 0.009 DBMET00259 0.051 0.016 DBMET00260 | DBMET00259 | |
| 0.029 | 0.027 | 0.029 | Sirtuin 2 inhibitor | |||
| 0.036 | 0.034 | 0.062 | Dopamine D5 agonist | 0.062 0.011 DBMET00260 | DBMET00260 | |
| 0.059 | 0.057 | 0.059 | Acetylcholine M5 receptor agonist | |||
| 0.123 | 0.122 | 0.174 | Heat shock protein 90 alpha antagonist | 0.174 0.067 DBMET00260 | DBMET00260 | |
| 0.151 | 0.149 | 0.151 | MAP kinase kinase 5 inhibitor | |||
| 0.018 | 0.017 | 0.021 | Antibiotic Anthracycline-like | 0.019 0.014 DBMET00259 0.021 0.01 DBMET00260 | DBMET00260 | |
| 0.04 | 0.039 | 0.04 | Dihydrofolate reductase inhibitor | |||
| 0.065 | 0.064 | 0.065 | Rho-associated kinase I inhibitor | |||
| 0.054 | 0.053 | 0.054 | NMDA receptor glycine site agonist | |||
| 0.04 | 0.04 | 0.049 | Mannosidase inhibitor | 0.049 0.027 DBMET00259 0.042 0.036 DBMET00260 | DBMET00259 | |
| 0.149 | 0.149 | 0.23 | Antiamyloidogenic | 0.23 0.081 DBMET00260 | DBMET00260 | |
| 0.035 | 0.035 | 0.038 | Toll-Like receptor 2 agonist | 0.038 0.032 DBMET00260 | DBMET00260 | |
| 0.16 | 0.162 | 0.242 | Hypoglycemic | 0.237 0.085 DBMET00259 0.242 0.081 DBMET00260 | DBMET00260 | |
| 0.043 | 0.044 | 0.047 | Glucose-6-phosphate isomerase inhibitor | 0.047 0.034 DBMET00259 0.045 0.039 DBMET00260 | DBMET00259 | |
| 0.01 | 0.012 | 0.013 | Glutamate (mGluR6) agonist | 0.013 0.008 DBMET00260 | DBMET00260 | |
| 0.031 | 0.035 | 0.032 | AMPA receptor agonist | 0.032 0.031 DBMET00259 | DBMET00259 | |
| 0.063 | 0.067 | 0.084 | Na+ K+ transporting ATPase inhibitor | 0.074 0.056 DBMET00259 0.084 0.047 DBMET00260 | DBMET00260 | |
| 0.103 | 0.108 | 0.138 | NADPH oxidase inhibitor | 0.138 0.064 DBMET00260 | DBMET00260 | |
| 0.14 | 0.146 | 0.196 | Dyrk kinase inhibitor | 0.196 0.101 DBMET00260 | DBMET00260 | |
| 0.057 | 0.064 | 0.064 | Sirtuin 1 inhibitor | 0.064 0.052 DBMET00260 | DBMET00260 | |
| 0.026 | 0.033 | 0.044 | Estrogen-related receptor alpha antagonist | 0.044 0.015 DBMET00260 | DBMET00260 | |
| 0.129 | 0.137 | 0.18 | Pyruvate kinase inhibitor | 0.18 0.093 DBMET00260 | DBMET00260 | |
| 0.027 | 0.035 | 0.032 | Free fatty acid receptor 1 antagonist | 0.032 0.026 DBMET00259 | DBMET00259 | |
| 0.068 | 0.076 | 0.084 | GABA B receptor agonist | 0.084 0.034 DBMET00260 | DBMET00260 | |
| 0.128 | 0.137 | 0.187 | Hepatoprotectant | 0.178 0.082 DBMET00259 0.187 0.074 DBMET00260 | DBMET00260 | |
| 0.124 | 0.134 | 0.149 | CF transmembrane conductance regulator agonist | 0.149 0.078 DBMET00260 | DBMET00260 | |
| 0.051 | 0.061 | 0.077 | Heat shock protein 90 beta antagonist | 0.077 0.022 DBMET00260 | DBMET00260 | |
| 0.061 | 0.072 | 0.115 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.115 0.031 DBMET00259 0.1 0.037 DBMET00260 | DBMET00259 | |
| 0.029 | 0.04 | 0.042 | Opioid delta receptor agonist | 0.042 0.018 DBMET00260 | DBMET00260 | |
| 0.05 | 0.063 | 0.057 | Purinergic P2X1 antagonist | 0.057 0.048 DBMET00260 | DBMET00260 | |
| 0.036 | 0.048 | 0.069 | Opioid mu receptor agonist | 0.069 0.02 DBMET00260 | DBMET00260 | |
| 0.074 | 0.088 | 0.081 | D-Ala-D-Ala ligase inhibitor | 0.081 0.065 DBMET00260 | DBMET00260 | |
| 0.024 | 0.038 | 0.034 | Arginase inhibitor | 0.034 0.028 DBMET00260 | DBMET00260 | |
| 0.049 | 0.064 | 0.059 | NMDA 2C receptor antagonist | 0.059 0.047 DBMET00260 | DBMET00260 | |
| 0.004 | 0.024 | 0.008 | Thyroid hormone beta agonist | 0.008 0.007 DBMET00260 | DBMET00260 | |
| 0.04 | 0.06 | 0.067 | Maillard reaction inhibitor | 0.067 0.03 DBMET00260 | DBMET00260 | |
| 0.043 | 0.063 | 0.112 | Opioid delta receptor antagonist | 0.112 0.028 DBMET00260 | DBMET00260 | |
| 0.111 | 0.132 | 0.161 | Heat shock protein 90 antagonist | 0.161 0.063 DBMET00260 | DBMET00260 | |
| 0.035 | 0.055 | 0.052 | Ribonucleoside-diphosphate reductase inhibitor | 0.052 0.039 DBMET00259 0.052 0.039 DBMET00260 | DBMET00260 | |
| 0.1 | 0.12 | 0.126 | Histone deacetylase SIRT1 inhibitor | 0.126 0.085 DBMET00260 | DBMET00260 | |
| 0.032 | 0.052 | 0.05 | Adenosine deaminase inhibitor | 0.05 0.03 DBMET00259 | DBMET00259 | |
| 0.071 | 0.093 | 0.089 | HIV-1 integrase (Overall Integration) inhibitor | 0.089 0.066 DBMET00259 | DBMET00259 | |
| 0.011 | 0.033 | 0.015 | Thyroid hormone alpha agonist | 0.015 0.014 DBMET00260 | DBMET00260 | |
| 0.035 | 0.057 | 0.052 | Ribonucleotide reductase inhibitor | 0.052 0.041 DBMET00259 0.052 0.041 DBMET00260 | DBMET00260 | |
| 0.043 | 0.067 | 0.058 | Vanilloid 2 antagonist | 0.058 0.026 DBMET00260 | DBMET00260 | |
| 0.069 | 0.094 | 0.084 | MAO A inhibitor | 0.084 0.077 DBMET00260 | DBMET00260 | |
| 0.026 | 0.053 | 0.033 | Ceramide glucosyltransferase inhibitor | 0.033 0.029 DBMET00259 | DBMET00259 | |
| 0.128 | 0.156 | 0.186 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.186 0.102 DBMET00260 | DBMET00260 | |
| 0.014 | 0.044 | 0.023 | Beta 1 adrenoreceptor agonist | 0.023 0.015 DBMET00259 | DBMET00259 | |
| 0.042 | 0.075 | 0.055 | Androgen agonist | 0.055 0.049 DBMET00260 | DBMET00260 | |
| 0.062 | 0.096 | 0.091 | Estrogen receptor alpha antagonist | 0.091 0.034 DBMET00260 | DBMET00260 | |
| 0.038 | 0.074 | 0.061 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.061 0.028 DBMET00260 | DBMET00260 | |
| 0.063 | 0.1 | 0.111 | Opioid antagonist | 0.111 0.04 DBMET00260 | DBMET00260 | |
| 0.014 | 0.051 | 0.023 | Dopamine D1 agonist | 0.023 0.015 DBMET00260 | DBMET00260 | |
| 0.058 | 0.102 | 0.088 | Carbonic anhydrase VI inhibitor | 0.088 0.049 DBMET00260 | DBMET00260 | |
| 0.096 | 0.14 | 0.126 | Thrombolytic | 0.126 0.103 DBMET00260 | DBMET00260 | |
| 0.029 | 0.073 | 0.058 | Opioid agonist | 0.058 0.031 DBMET00260 | DBMET00260 | |
| 0.04 | 0.086 | 0.091 | Opioid mu receptor antagonist | 0.091 0.035 DBMET00260 | DBMET00260 | |
| 0.073 | 0.121 | 0.096 | Adenylate cyclase inhibitor | 0.096 0.088 DBMET00260 | DBMET00260 | |
| 0.036 | 0.086 | 0.05 | Glucose-6-phosphate translocase inhibitor | 0.05 0.039 DBMET00260 | DBMET00260 | |
| 0.038 | 0.102 | 0.071 | Antineoplastic antibiotic | 0.071 0.064 DBMET00259 0.071 0.065 DBMET00260 | DBMET00260 | |
| 0.068 | 0.135 | 0.099 | Xanthine oxidase inhibitor | 0.099 0.061 DBMET00260 | DBMET00260 | |
| 0.105 | 0.18 | 0.176 | Interleukin antagonist | 0.176 0.099 DBMET00260 | DBMET00260 | |
| 0.097 | 0.173 | 0.115 | Papain-like protease (SARS coronavirus) inhibitor | 0.115 0.097 DBMET00260 | DBMET00260 | |
| 0.042 | 0.127 | 0.076 | Analgesic, opioid | 0.076 0.053 DBMET00260 | DBMET00260 | |
| 0.028 | 0.115 | 0.073 | Purinergic P2X2 antagonist | 0.073 0.044 DBMET00260 | DBMET00260 | |
| 0.11 | 0.209 | 0.311 | Free radical scavenger | 0.311 0.049 DBMET00260 | DBMET00260 | |
| 0.033 | 0.144 | 0.059 | Neuraminidase (influenza) inhibitor | 0.059 0.055 DBMET00260 | DBMET00260 | |
| 0.07 | 0.187 | 0.155 | Estrogen antagonist | 0.155 0.022 DBMET00260 | DBMET00260 | |
| 0.089 | 0.209 | 0.155 | Nitric oxide antagonist | 0.153 0.092 DBMET00259 0.155 0.09 DBMET00260 | DBMET00260 | |
| 0.044 | 0.173 | 0.098 | 5-Lipoxygenase inhibitor | 0.098 0.066 DBMET00260 | DBMET00260 | |
| 0.054 | 0.186 | 0.138 | Estrogen receptor beta antagonist | 0.138 0.019 DBMET00260 | DBMET00260 | |
| 0.144 | 0.28 | 0.292 | Sodium/bile acid cotransporter inhibitor | 0.292 0.087 DBMET00260 | DBMET00260 | |
| 0.053 | 0.197 | 0.11 | DNA polymerase I inhibitor | 0.11 0.076 DBMET00260 | DBMET00260 | |
| 0.016 | 0.168 | 0.033 | Estrogen-related receptor beta antagonist | 0.033 0.021 DBMET00260 | DBMET00260 | |
| 0.106 | 0.29 | 0.178 | 12-Lipoxygenase inhibitor | 0.178 0.175 DBMET00260 | DBMET00260 | |
| 0.007 | 0.23 | 0.048 | Estrogen agonist | 0.048 0.036 DBMET00260 | DBMET00260 | |
| 0.048 | 0.297 | 0.155 | Amyloid beta aggregation inhibitor | 0.155 0.104 DBMET00260 | DBMET00260 | |
| 0.027 | 0.327 | 0.231 | Bronchodilator | 0.231 0.014 DBMET00259 | DBMET00259 | |
| 0.076 | 0.406 | 0.162 | Growth factor agonist | 0.162 0.117 DBMET00259 | DBMET00259 | |
| 0.045 | 0.386 | 0.112 | Interleukin 4 antagonist | 0.112 0.098 DBMET00260 | DBMET00260 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |